
Taiho Pharmaceutical Co Ltd - Strategic SWOT Analysis Review
Description
Taiho Pharmaceutical Co Ltd - Strategic SWOT Analysis Review
- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group, is a global pharmaceutical company primarily engaged in the research, development, and supply of pharmaceutical products. The company's main activities include the development of innovative drugs, particularly in the areas of oncology and immune-related diseases. Taiho's major products include a range of prescription drugs, such as Lonsurf and other consumer healthcare products. The company serves a broad customer base, including patients, healthcare professionals, and medical staff, providing solutions for various health conditions and diseases. The company's products are available worldwide. Taiho operates globally, with business locations in the US, Europe, Asia, and Oceania. Taiho is headquartered in Tokyo, Japan.
Taiho Pharmaceutical Co Ltd Key Recent Developments
Jan 08,2024: Taiho Ventures Expands Investment Pool to $400 Million to Continue Quality Investments and Accelerate Open Innovation
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
28 Pages
- Section 1 - About the Company
- Taiho Pharmaceutical Co Ltd - Key Facts
- Taiho Pharmaceutical Co Ltd - Key Employees
- Taiho Pharmaceutical Co Ltd - Major Products and Services
- Taiho Pharmaceutical Co Ltd - History
- Taiho Pharmaceutical Co Ltd - Company Statement
- Taiho Pharmaceutical Co Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Taiho Pharmaceutical Co Ltd - Business Description
- R&D Overview
- Taiho Pharmaceutical Co Ltd - SWOT Analysis
- SWOT Analysis - Overview
- Taiho Pharmaceutical Co Ltd - Strengths
- Taiho Pharmaceutical Co Ltd - Weaknesses
- Taiho Pharmaceutical Co Ltd - Opportunities
- Taiho Pharmaceutical Co Ltd - Threats
- Taiho Pharmaceutical Co Ltd - Key Competitors
- Section 3 – Company’s Lifesciences Financial Deals and Alliances
- Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Taiho Pharmaceutical Co Ltd, Recent Deals Summary
- Section 4 – Company’s Recent Developments
- Jan 08, 2024: Taiho Ventures Expands Investment Pool to $400 Million to Continue Quality Investments and Accelerate Open Innovation
- Section 5 – Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Taiho Pharmaceutical Co Ltd, Key Facts
- Taiho Pharmaceutical Co Ltd, Key Employees
- Taiho Pharmaceutical Co Ltd, Major Products and Services
- Taiho Pharmaceutical Co Ltd, History
- Taiho Pharmaceutical Co Ltd, Subsidiaries
- Taiho Pharmaceutical Co Ltd, Key Competitors
- Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Taiho Pharmaceutical Co Ltd, Recent Deals Summary
- List of Figures
- Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.